Subscribe by Email

About the Blog

The Active Ingredient features expert insights and commentary from leaders of ZS Associates' global pharmaceuticals practice.

Search by Topic

see all

How to Get Pharma Leaders to Wrap Their Minds—and Their Arms—Around Advanced Analytics

Posted by Shreyas Murthi on Mon, Mar 11, 2019

 

The business of pharma is becoming more data-driven—from R&D to commercial—yet many pharma companies still struggle to garner leaders’ buy-in to build and operate the analytics programs that they need to fuel their success. They face tough challenges, including overcoming skepticism, proving the program’s value and scalability, finding the right talent and ensuring organizational collaboration.    

Read More

Topics: predictive analytics, Analytics, pharmaceuticals, change management, data analytics, pharma companies, artificial intelligence & pharma, cutting-edge analytics, technology investment, advanced analytics, personalized analytics, analytics maturity

The Death of Dashboards, and the Promise of Personalized Analytics

Posted by ZS Editors on Mon, Jan 07, 2019

Multiple factors are colliding to encourage the need for personalized analytics. The ever-expanding explosion of data is forcing companies to consider more nimble, automated solutions that simplify the user experience. The need for competitive advantage in a crowded marketplace is inspiring companies to arm reps with sales tools that give them an edge. Reps are increasingly expecting the kind of user experience that they get from consumer applications. The list goes on.

Personalization conjures a future where reps are no longer bombarded with information and expected to draw their own insights. In this future, AI-driven insights come to them as alerts on their mobile devices, personalized to their needs and customers, and delivered at the best possible time. 

But this is pharma. Surely the spreadsheets and dashboards will persist, right?

Read More

Topics: artificial intelligence, analytics disruption, commercial analytics, artificial intelligence & pharma, cutting-edge analytics, advanced analytics, personalized analytics, analytics maturity, data and insights

Making the Case for a New Analytics Consumption Model

Posted by ZS Editors on Thu, Nov 29, 2018

Industries like retail and technology are transitioning to an AI-driven, personalized approach to surfacing insights to end users, and they’re reaping the benefits. Life sciences companies have the same opportunity to capitalize on the runaway growth in data and rethink the way that analytics are consumed.  

ZS recently partnered with IDC to study how commercial life sciences teams are currently consuming data, and to determine their data and analytics pain points. The study revealed that sales and marketing professionals in life sciences want

Read More

Topics: Analytics, artificial intelligence, AI, data and analytics, analytics disruption, commercial analytics, artificial intelligence & pharma, cutting-edge analytics, advanced analytics, personalized analytics, analytics maturity, pharma commercial model

AI Across the Pond: Implementing Next Best Actions in Europe

Posted by Zainul Jafferji on Wed, Jun 27, 2018

There’s no shortage of news about how artificial intelligence techniques are helping us engage customers better in healthcare. Many pharmaceutical companies have visions of Amazon-like targeting serving up Netflix-esque recommendations on how to engage customers better with the right channels, content and cadence.

Read More

Topics: customer experience, Pharma, pharmaceuticals, personalization, Europe, artificial intelligence, EU, AI, machine learning, next-best actions, european market, artificial intelligence & pharma, personalized analytics

Pharma Is Ready for Personalized Analytics

Posted by Jérôme Chabrillat on Mon, Jun 04, 2018

A sales rep preparing for her week isn’t thinking: What’s in my sales dashboard? What is my progress towards my call plan? She’s thinking: What are the burning issues in my territory this week? How should I adjust my plan based on the latest events and information that I have? Then she manually navigates her way through dashboards and reports to find these answers.

This slow, manual process isn’t unique to reps. It also applies to HQ functions, and it will only get more difficult over time as new data become available. Accessing the right information at the right time and in the right way is critical to more effective decisions and efficient execution. User-centered design, technology and artificial intelligence can transform this experience with personalized analytics.

Read More

Topics: eyeforpharma, data and analytics, artificial intelligence & pharma, personalized analytics

Subscribe to The Active Ingredient
SUBSCRIBE

Get 'THE ACTIVE INGREDIENT' Updates

Subscribe to receive email notifications whenever new blog posts are published.

×